Keywords: Dr Reddy's Laboratories, Financial results, Quarter ended June 2012

Dr Reddy's posts 28% revenue growth for fiscal 1st-qtr 2013

Article | 20 July 2012

Print This

India’s second largest drugmaker Dr Reddy’s Laboratories (NYSE: RDY) yesterday released unaudited consolidated financial results for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in